Studies have shown that AMPK activation suppresses proliferation of a variety of tumor cells as well as nonmalignant cells, which indicates that activation of AMPK is a promising strategy for the treatment of cancer as well as other human diseases [14,15,16]. This evidence concerns the gene PRKAA2 and cancer.